← All indications
Dengue
An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
Subtype terms (1)
More specific conditions that are subtypes of Dengue in the MeSH hierarchy.
- Severe Dengue
30 drugs (20 approved, 10 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (18)
- montelukast
- ivermectin
- pneumococcal 13-valent conjugate vaccine
- ribavirin
- hepatitis a vaccine, inactivated
- yellow fever vaccine 17d strain
- human papillomavirus 9-valent vaccine, recombinant
- live, attenuated, dengue serotype 1, 2, 3, 4 virus
- measles, mumps, and rubella vaccine
- hpv 16/18 vaccine
- haemophilus influenzae type b conjugate vaccine
- metadelfene
- methylcephaeline
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- denvax
- papaya
- Bivalent group A and C meningococcal vaccine
- vla1555
Phase 2 trials (33)
- metformin
- vitamin d3
- urea
- butantan
- mdl 28574
- ic14
- inactivated rabies vaccine
- modipafant
- tivantinib
- inactivated japanese encephalitis vaccine
- den vaccine f17
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- live attenuated varicella vaccine
- rden2delta30-7169
- tdenv-f17
- t-den- f19
- tdenv-piv
- tv003
- tv005
- chloroquine
- ombitasvir
- bivalent cyd-1,3 dengue
- bivalent cyd-2,4 dengue
- chimerivax
- inactivated varicella vaccine
- anakinra
- Molnupiravir
- jnj-64281802
- at-752
- eyu688
- +3 more
Phase 1 trials (25)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (26)
- Inviragen
- Novo Nordisk
- GlaxoSmithKline
- Implicit Bioscience
- Medigen Biotechnology Corporation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institute of Allergy and Infectious Diseases (NIAID)
- United States Army
- Johns Hopkins University
- Siriraj Hospital
- University of Vermont
- Department of Defense
- International Center for Diarrheal Disease Research
- Guangzhou University
- National Taiwan University
- University of Oxford
- Janssen Pharmaceutica NV
- University of Sao Paulo
- Butantan Foundation
- Caparra Internal Medicine Research Center
- Ponce School of Medicine
- San Juan Batista Medical School
- Tropical Diseases Hospital, Ho Chi Minh City
- 60 Degrees Pharmaceuticals LLC
- Banco Nacional de Desenvolvimento Economico e Social
- Government of Taiwan
Organization Involved with Phase 1 Indications (18)
- PPD
- Roche
- Merck
- Inovio Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- Vical
- United States Navy
- University of Pennsylvania
- Fr Muller Homoeopathic Medical College
- Universidad de Antioquia
- Universidad El Bosque, Bogotá
- University of Puerto Rico
- GeneOne Life Science
- State University of New York, Syracuse
- Hawaii Biotech
- Allied Research International
- George Washington University
- Hospital Infantil de Niño Jesús de Barranquilla (HINJ)
Organization Involved with Other Experimental Indications (1)